Lv2
140 积分 2024-04-30 加入
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
3个月前
已完结
Inefficient CAR-proximal signaling blunts antigen sensitivity
3个月前
已完结
Cancer cell therapies: global clinical trial trends and emerging directions
4个月前
已完结
Correlation Between Chimeric Antigen Receptor T‐Cell Pharmacokinetic Data Measured by Flow Cytometry and Quantitative Polymerase Chain Reaction
4个月前
已完结
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
4个月前
已完结
Presetting CAR-T cells during ex vivo bio-manufacturing
4个月前
已完结
Cytokines and Immune Effector Cell Therapy
4个月前
已完结
Impact of Serum/Xeno‐Free Medium and Cytokine Supplementation on CAR‐T Cell Therapy Manufacturing in Stirred Tank Bioreactors
4个月前
已完结
皖公网安备34019202002308
